SBIR/STTR Research Award

CHROMIUM ANALYSIS AND DIABETES

Award identifier d2d0bc6f9558a913d8070803d98cf6a94511d9fd128c13a10a21445504eb6c8eAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$99,878

Program and phase

SBIR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
BIOPHYSICS ASSAY LABORATORY, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
KZDPB1XGZ6H1
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Diabetes is one of the most costly health problems in America and the seventh leading cause of death Chromium has been implicated in the regulation of insulin metabolism and a number of the signs and symptoms of diabetes are shared in common with demonstrated chromium deficiency These include impaired glucose tolerance, fasting hyperglycemia, glucosuria, hypoglycemia, elevated circulating insulin, decreased insulin receptor number, and peripheral neuropathy The Office of Dietary Supplements (ODS), the National Center for Complementary and Alternative Medicine (NCCAM), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) have invited applications for basic and clinical studies of the role of chromium as adjuvant therapy in type 2 diabetes and/or impaired glucose tolerance Studies report that chromium supplementation may improve diabetes control but one of the major obstacles in evaluating the biological effects of chromium involves assessing chromium status by a simple, readily available analytical method BioPAL, utilizing neutron activation analysis (NAA), proposes to develop a nonradioactive, convenient, and standardized commercial assay for chromium in biological tissues and fluids free of the problems of complicated sample preparation and potential contamination encountered with presently used techniques Our long-term goal (Phase II) is to develop advanced technology to significantly, improve the lower-limits of sensitivity for chromium as compared to current methods, including current NAA methods The assessment of chromium levels and their relationship to insulin sensitivity as well as the possible value of chromium in the control of hypoglycemia and various other symptoms associated either with diabetes or related pathologies would be not only a valuable tool in research but a means for determining individual chromium levels by a routine, non-destructive and non-invasive technique Ultimately these methods could be developed into a simple kit for use by clinicians or even individuals Similar methods can be adapted for the determination of other trace metals from the same sample in a single analysis.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

19 SBIR/STTR records share this UEI (1999–2013). Reported award amounts total $5,794,307. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.